Galectin Therapeutics Inc. (GALT)

[biotech2010]

Psoriasis before and after photos posted by GALT on the CEO Perspective blog: http://perspectives.galectintherapeutics.com/photographs-of-improvement-in-moderate-to-severe-plaque-psoriasis/

As a means of comparison, here are before and after photos relating to treatment using Humira for psoriasis: https://www.humira.com/psoriasis/before-and-after-pictures

Humira is approved for this treatment by the FDA and costs about $2500 per dose.

I can only speak for myself but this is really impressive and it clearly shows that the way to achieve the PASI 75 level is to enroll patients with very acute psoriasis (Patient 4) as opposed to those with lesser psoriasis (patients 1 and 2). You can easily see from the Humira trial photos that they found patients with very acute psoriasis, far more acute than the preliminary GALT patients

In my mind this might be the most important thing GALT has ever posted publicly since it shows clear improvement in a format that is very easy to understand